COYA vs HPQ · rev $7.9M vs P/E 8.6, rev $44.52B
Coya Therapeutics, Inc. Common Stock (COYA) versus HP Inc (HPQ) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
COYA currently screens at market cap $118.0M. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Not investment advice. Open the COYA and HPQ stock pages for the full models.
Not investment advice.